Horizon Two: HR NDMM (MMRC-100)
Horizon Two: HR NDMM (MMRC-100)
Recruiting · NCT07053436 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Horizon Two: HR NDMM (MMRC-100) | High Risk Newly Diagnosed Multiple Myeloma | Recruiting | Phase 2 | 2026-10-02 | NCT07053436 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Multiple Myeloma Research Consortium | 9 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Levine Cancer institute | Charlotte | United States | 2 |
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| City of Hope | Duarte | United States | 238 |
| Emory University | Atlanta | United States | 1 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Mayo Clinic | Rochester | United States | 68 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Mt. Sinai School of Medicine | New York | United States | 5 |
| Tennessee Oncology | Nashville | United States | 77 |
| UChicago Medicine | Chicago | United States | 5 |
| UNC | Chapel Hill | United States | 2 |
| Washington University Medical Center | St Louis | United States | 2 |